Mitul Gandhi, MD

Community oncology practices can deliver chimeric antigen receptor (CAR) T-cell therapy safely, effectively, and in a sustained manner.

Explore the significance of MRD negativity in cancer prognosis and its implications for treatment strategies in community-based practices.

Mitul Gandhi, MD, discusses the current landscape for patients with diffuse large B-cell lymphoma and what may be coming in the future.